Aethlon Medical Publishes Preclinical Data on the Hemopurifier® in Transplant Immunology Journal
Portfolio Pulse from
Aethlon Medical has published preclinical data in the Transplant Immunology journal, suggesting expanded therapeutic potential for its Hemopurifier® device beyond virology and oncology. The study supports further evaluation of the device in kidney transplantation.
March 10, 2025 | 12:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Aethlon Medical's Hemopurifier® shows potential for expanded use in kidney transplantation, as per new preclinical data. This could enhance the device's marketability and application scope.
The publication of preclinical data in a peer-reviewed journal suggests scientific validation and potential for expanded use of the Hemopurifier®. This could lead to increased interest and investment in Aethlon Medical, positively impacting its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100